Kelli DuCloux – Trademark Portfolio
Entity Type: 01
Kelli DuCloux holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 18 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 12 are pending. Notable registered marks include DR. KELLI, DR. KELLI DUCLOUX, DR. KELLI'S PURPLE UNICORN STRATEGY, and DR. KELLI'S STOCK OPTIONS TRADING ACADEMY. The owner is based in Perris, CA.
23063 Miners Rd.
Perris, CA 92570
Showing of trademarks Trademarks
Trademark Classifications
Kelli DuCloux's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Kelli DuCloux have?
Kelli DuCloux has 18 U.S. trademarks filed with the USPTO. Of these, 4 registered, 12 pending, 2 abandoned.
What trademark classes does Kelli DuCloux file in?
Kelli DuCloux files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 9 (Computers & Electronics). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Kelli DuCloux's most well-known trademarks?
Kelli DuCloux's registered trademark portfolio includes well-known marks such as DR. KELLI, DR. KELLI DUCLOUX, DR. KELLI'S PURPLE UNICORN STRATEGY, and DR. KELLI'S STOCK OPTIONS TRADING ACADEMY. These are among 4 currently registered trademarks in the portfolio.
What is Kelli DuCloux's trademark registration success rate?
Kelli DuCloux has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 12 applications are pending review.